Close Menu

NEW YORK (GenomeWeb) – Bio-Rad Laboratories has received clearance from the US Food and Drug Administration for its first liquid biopsy assay and Droplet Digital PCR system for diagnostic use, the firm announced today.

The test is designed for monitoring treatment response in chronic myeloid leukemia and is also the first-ever digital PCR product to receive FDA clearance, according to the company.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.